|
End-of-day quote
Shenzhen S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 2.880 CNY | -2.37% |
|
-11.11% | -6.19% |
| Market Cap | 6.42B 963M 864M 799M 724M 1.35B 91.74B 1.37B 9.55B 3.81B 48B 3.61B 3.54B 152B | P/E 2024 |
24.2x | P/E 2025 | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5.58B 838M 751M 695M 629M 1.18B 79.77B 1.19B 8.31B 3.31B 41.74B 3.14B 3.08B 133B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 2.82x |
| Free-Float |
90.2% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.37% | ||
| 1 week | -11.11% | ||
| Current month | -21.10% | ||
| 1 month | -16.52% | ||
| 6 months | -20.22% | ||
| Current year | -6.19% |
| 1 week | 2.87 |  | 3.09 |
| 1 month | 2.87 | | 3.78 |
| Current year | 2.37 | | 5.1 |
| 1 year | 2.37 | | 5.1 |
| 3 years | 1.66 | | 5.1 |
| 5 years | 1.66 | | 5.1 |
| 10 years | 1.66 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Feng Guo
CEO | Chief Executive Officer | 53 | 26/12/2022 |
Kang Zhou
PRN | Corporate Officer/Principal | 42 | 18/04/2018 |
Yue Yin Liu
PRN | Corporate Officer/Principal | 40 | 23/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Yin Liu
BRD | Director/Board Member | 40 | 14/03/2025 |
Lei Feng Guo
BRD | Director/Board Member | 53 | 11/11/2022 |
Kang Zhou
BRD | Director/Board Member | 42 | 11/11/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/7/25 | Sell | 587,500 | 0.0283% | |||
| 2/7/25 | Sell | Director | 259,600 | 0.0125% | ||
| 2/7/25 | Sell | 587,500 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.37% | -11.11% | -10.00% | +18.52% | 987M | |
| +5.87% | +5.07% | +68.77% | +142.70% | 1,148B | |
| +1.46% | +2.87% | +47.53% | +87.23% | 652B | |
| +1.36% | +1.80% | +28.95% | +104.61% | 505B | |
| +0.84% | +2.75% | +54.72% | +66.97% | 384B | |
| +4.65% | +0.69% | +71.24% | +44.39% | 348B | |
| +2.59% | +3.09% | +34.88% | +56.99% | 294B | |
| +2.08% | +0.65% | +4.01% | +27.85% | 264B | |
| +1.71% | +3.20% | +58.21% | +75.39% | 244B | |
| +1.52% | +2.87% | +36.46% | +107.92% | 197B | |
| Average | +2.05% | +0.60% | +39.48% | +73.26% | 403.81B | |
| Weighted average by Cap. | +3.17% | +1.50% | +50.30% | +93.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.44B 366M 328M 304M 275M 514M 34.87B 520M 3.63B 1.45B 18.24B 1.37B 1.34B 57.92B | 2.14B 320M 287M 266M 241M 450M 30.5B 455M 3.18B 1.27B 15.96B 1.2B 1.18B 50.68B |
| Net income | 233M 34.91M 31.32M 28.96M 26.23M 49M 3.32B 49.59M 346M 138M 1.74B 131M 128M 5.52B | 377M 56.53M 50.72M 46.89M 42.47M 79.34M 5.38B 80.3M 561M 223M 2.82B 212M 208M 8.94B |
| Net Debt | -509M -76.3M -68.45M -63.29M -57.32M -107M -7.27B -108M -757M -301M -3.8B -286M -280M -12.07B | -838M -126M -113M -104M -94.43M -176M -11.97B -179M -1.25B -497M -6.26B -472M -462M -19.89B |
Employees
2,350
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | CN¥2.880 | -2.37% | 117,068,100 |
| 28/10/26 | CN¥2.950 | +1.37% | 142,305,478 |
| 27/10/26 | CN¥2.910 | -3.32% | 118,166,342 |
| 26/10/26 | CN¥3.010 | -2.27% | 136,398,152 |
| 23/10/26 | CN¥3.080 | +1.32% | 203,469,986 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002437 Stock
Select your edition
All financial news and data tailored to specific country editions
